title: Symptom score change and patient versus doctor satisfaction in overactive bladder before and after anti-muscarinic treatment.
abstract: OBJECTIVE
  To evaluate voiding symptoms and questionnaire score change before and after anti-muscarinic treatment and evaluate the correlation of agreement in patient and doctor satisfaction after treatment.
  
  
  METHODS
  Forty women newly diagnosed with overactive bladder (OAB), attending the urogynecology clinic at Chulalongkorn Hospital during April-June 2011 were recruited. Tolterodine 4 mg orally once daily was given for 4 weeks. A voiding diary and Thai version of the OAB questionnaires eight-item Overactive Bladder awareness tool (OAB-v8), Overactive Bladder Symptoms Score (OABSS) and Overactive Bladder QOL (OABq) were completed before and at the end of treatment. At the end of the trial, self-report patient satisfaction, and doctor satisfaction (according to symptom improvement in the voiding diary) were assessed. Student's t-test and weighted kappa coefficients were used in statistical analysis. Sample size was calculated from an OAB questionnaire pilot study with 20% addition for loss to follow up.
  
  
  RESULTS
  All voiding parameters and questionnaire scores (OAB-v8, OABSS and OABq) were improved after treatment. Weighted kappa was only 0.06, between doctor and patient satisfaction.
  
  
  CONCLUSIONS
  OAB-v8 and OABSS questionnaires can be used as screening and follow-up tools. There is poor agreement between patient and doctor satisfaction. Satisfaction should therefore be measured from the patient's perspective.
authors.affiliation: Female Pelvic Medicine and Reconstructive Surgery Division, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
authors.forename: Suvit
authors.initials: S
authors.lastname: Bunyavejchevin
mesh_terms: D000328:Adult; D000368:Aged; D001291:Attitude of Health Personnel; D005260:Female; D006786:Hospitals, Urban; D006801:Humans; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D010044:Outpatient Clinics, Hospital; D017060:Patient Satisfaction; D010820:Physicians; D057566:Self Report; D012720:Severity of Illness Index; D013785:Thailand; D000068737:Tolterodine Tartrate / Q000009:adverse effects / Q000627:therapeutic use*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*; D014554:Urination / Q000187:drug effects
chemical_list: D018727:Muscarinic Antagonists; D000068737:Tolterodine Tartrate
keywords: anti-muscarinic; overactive bladder; questionnaire; satisfaction; symptom